Status:
COMPLETED
SOLFA Study to Explore the Thrombogenicity of a Dialyzer
Lead Sponsor:
Fundación Senefro
Conditions:
End Stage Renal Disease on Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prospective, multicenter, randomized, crossover, non-masked study to evaluate the impact on the thrombogenicity of the haemodialysis circuit by comparing synthetic haemodialysers against the ATA membr...
Detailed Description
This is a prospective, multicenter, randomized, crossover, non-masked study that included 32 patients from 4 Spanish hospitals. The objective of the present work is to evaluate the impact on the thro...
Eligibility Criteria
Inclusion
- Patients over 18 years of age.
- Patients in a chronic haemodialysis program who had been on dialysis for more than three months were included.
- Patients provided informed consent.
Exclusion
- allergies to synthetic membranes
- allergies to heparin
- patients receiving anticoagulant treatment
- women Pregnant
- breastfeeding
- patients with cognitive impairment
Key Trial Info
Start Date :
January 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2023
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06505616
Start Date
January 17 2022
End Date
May 20 2023
Last Update
July 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Infanta Leonor
Madrid, Spain, 28031